Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
injectable filler
|
| gptkbp:administeredBy |
injection
|
| gptkbp:alternativeTo |
surgical implants
|
| gptkbp:duration_of_effect |
12 to 18 months
|
| https://www.w3.org/2000/01/rdf-schema#label |
Macrolane
|
| gptkbp:introduced |
2008
|
| gptkbp:mainIngredient |
hyaluronic acid
|
| gptkbp:manufacturer |
gptkb:Q-Med
|
| gptkbp:marketedIn |
gptkb:Europe
|
| gptkbp:not_approved_by |
gptkb:US_FDA
|
| gptkbp:not_permanent |
true
|
| gptkbp:requires |
local anesthesia
|
| gptkbp:sideEffect |
asymmetry
infection swelling bruising lumpiness |
| gptkbp:usedFor |
breast enhancement
correction of soft tissue defects cosmetic body contouring |
| gptkbp:withdrawn |
difficulty in breast cancer screening
|
| gptkbp:withdrawn_for_breast_enhancement |
2012
|
| gptkbp:bfsParent |
gptkb:Q-Med
|
| gptkbp:bfsLayer |
8
|